“NEOADJUVANT FOR PATIENTS WITH HIGH AND VERY HIGH RISK PROSTATE CANCER”. Voprosy Onkologii, vol. 65, no. 5, May 2019, pp. 726-35, https://doi.org/10.37469/0507-3758-2019-65-5-726-735.